Cited by 41Traffic and Road SafetySubstance Abuse Treatment and OutcomesForensic Toxicology and Drug Analysis

Effects of dexamphetamine with and without alcohol on simulated driving

Open access
Simons, Ries, Martens, Marieke, Ramaekers, Jan, Krul, Arno, Klöpping-Ketelaars, Ineke, Skopp, Gisela·2012·Psychopharmacology

Abstract

RATIONALE: In party circuits dexamphetamine is frequently used in combination with alcohol. It is hypothesized that co-administration of dexamphetamine to alcohol might reduce the sedative effects of alcohol, but may potentiate risk-taking behaviour. OBJECTIVES: The study was aimed at assessing the effects of alcohol, dexamphetamine and the combination of both on simulated driving and cognitive performance. METHOD: Eighteen subjects participated in a randomized, crossover, placebo-controlled study employing four conditions: 10 mg dexamphetamine, 0.8 g/kg alcohol, 10 mg dexamphetamine + 0.8 g/kg alcohol, and placebo. Fundamental driving skills and risk-taking behaviour were assessed in a driving simulator. Subjects also completed vigilance and divided attention tasks, and subjective ratings. RESULTS: Mean BAC levels during simulated driving were between 0.91‰ and 0.64‰. Subjects using alcohol showed a significantly larger mean standard deviation of lateral position and shorter accepted gap time and distance. Use of alcohol or dexamphetamine + alcohol was associated with a higher frequency of red light running and collisions than the dexamphetamine or placebo conditions. Performance of vigilance and divided attention tasks was significantly impaired in the alcohol condition and, to a lesser degree, in the dexamphetamine + alcohol condition. CONCLUSION: Single doses of 0.8 g/kg alcohol increased risk-taking behaviours and impaired tracking, attention and reaction time during a 3-h period after drinking when BACs declined from 0.9 to 0.2 mg/ml. The stimulatory effects of co-administration of dexamphetamine 10 mg were not sufficient to overcome the impairing effects of alcohol on skills related to driving.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00213-011-2549-0

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Amphetamine and its derivatives have modest cognitive benefits as prescription stimulants and enhance motivation and energy in healthy subjects.

    “Although AMP and its derivatives have modest cognitive benefits as prescription stimulants and enhance motivation and energy in heathy subjects, studies have shown that they have limited cognitive effects in heathy subjects (see Ilieva & Farah, 2013; Simons et al., 2012).”

    From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Simons et al., 2012

    The Results (Cognitive tasks) report that participants taking dexamphetamine felt more energetic, while the Discussion describes benefits on some attention and driving tasks alongside mixed effects in other domains. The paper does not establish enhanced motivation or modest cognitive benefits in the context of prescription stimulant treatment. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Amphetamine has limited cognitive effects in healthy subjects.

    “Although AMP and its derivatives have modest cognitive benefits as prescription stimulants and enhance motivation and energy in heathy subjects, studies have shown that they have limited cognitive effects in heathy subjects (see Ilieva & Farah, 2013; Simons et al., 2012).”

    From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Simons et al., 2012

    The Results (Cognitive tasks; page unavailable) report no significant differences on several tasks and a nonsignificant advantage for dexamphetamine on vigilance, supporting limited effects on the measures tested. But the Discussion reports better divided-attention performance, and the study tested one 10 mg dose of dexamphetamine in a small group of volunteers; it does not establish a general claim about amphetamine’s cognitive effects in healthy subjects. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Zijlstra FRH (1993) Efficiency in work behavior. A design approach for modern tools. PhD thesis, Delft University of Technology, Delft

Cited by

Sorted by citations

Authors
Simons, R., Martens, M., Ramaekers, J., Krul, A., Klöpping-Ketelaars, I., & Skopp, G.
Affiliations
  • Netherlands Organisation for Applied Scientific Research (NL)
  • Maastricht University (NL)
  • University Hospital Heidelberg (DE)
Corresponding author
Simons, Ries
Venue
Psychopharmacology
Published
2011-11-11
Volume
222
Issue
3
Pages
391-399
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2124010291
Cited by
41
References
29
Citations by year
2024: 1 · 2023: 2 · 2022: 6 · 2021: 5 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 2 · 2013: 4 · 2012: 2
FWCI
8.37
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Psychopharmacology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by-nc)
  • University of Twente Research Information (submittedVersion, other-oa)
  • Repository hosted by TU Delft Library (TU Delft) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • European Commission (TREN-05-FP6TR-S07.61320-518404-DRUID)
  • Rijksuniversiteit Groningen
Topics
  • Physical Sciences › Engineering › Safety, Risk, Reliability and Quality › Traffic and Road Safety
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords
d-amphetamine, alcohol, drug co-administration, driving simulation, driving performance, risk-taking, cognitive impairment, sustained attention, divided attention, reaction time, blood alcohol concentration
MeSH terms
Adult, Ethanol, Central Nervous System Stimulants, Automobile Driving, Dextroamphetamine, Dose-Response Relationship, Drug, Double-Blind Method, Humans, Male, Psychomotor Performance, Surveys and Questionnaires, Sleep, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review